亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Novel Cell Penetrating Peptides

技術優勢
The cell penetrating peptides (CPPs) identified in this technology are of shorter length and simpler structure than most known CPPs. Due to these characteristics, these CPPs are more cost effective to produce and are effective in penetrating cell membranes to deliver cargo.
技術應用
CPPs are an effective way to deliver molecules and agents to the interior of a cell. These peptides may be used in therapeutic applications and demonstrate antimicrobial properties.
詳細技術說明
None
*Abstract
Molecules useful in the treatment of disease in humans and animals. This technology identifies several highly potent cell penetrating peptides (CPPs) that are soluble and nontoxic.
*Principal Investigation

Name: William Wimley

Department:

附加資料
Inventor: Zheng, Yi | Williams, David A.
Priority Number: US7915384B2
IPC Current: C07K001400 | A01N003718 | C07K001447 | C12N000914
US Class: 530350 | 514002
Assignee Applicant: Children's Hospital Medical Center,Cincinnati
Title: Chimeric peptides for the regulation of GTPases
Usefulness: Chimeric peptides for the regulation of GTPases
Summary: The chimeric polypeptide and compositions are useful for treating a disease related to up-regulation of GTPase activity, e.g. cancer (claimed).
主要類別
診斷/治療
細分類別
癌症/腫瘤
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備